Skip to main content
Glama

Medicare Lab Test Lookup

medicare_lab_test_lookup
Read-onlyIdempotent

Resolve a branded molecular or genomic lab test by its commercial name (e.g. Signatera, Guardant360 CDx, FoundationOne CDx, FoundationOne Liquid CDx, Tempus xT CDx, DecisionDx-Melanoma, Envisia, Shield) to its CPT PLA / HCPCS billing code, the lab that runs it, what Medicare pays for it now on the Clinical Laboratory Fee Schedule, and the MolDX local coverage determinations (LCDs) and billing-and-coding articles for its test category. Answers "what does Medicare pay for Signatera", "what is the PLA code for Guardant360", "which MolDX LCD covers this test". Also accepts a lab name (e.g. "Natera") or a code. Also covers non-ADLT branded MAAA tests (Oncotype DX, Prosigna, MammaPrint, EndoPredict, Breast Cancer Index, Cologuard, Prolaris, Decipher, Afirma, ConfirmMDx, 4Kscore) and any test whose lab registered its code in the NCBI Genetic Testing Registry. Resolves in order: the CMS list of Advanced Diagnostic Laboratory Tests (ADLTs), a brand-to-code table of MAAA tests with MolDX billing articles, then NCBI GTR live; a test found in none returns brand_not_found naming every source checked. Sourced from CMS (ADLT list, Clinical Laboratory Fee Schedule, Medicare Coverage Database) and NCBI GTR.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
testYesThe test's brand or commercial name ("Signatera", "Guardant360 CDx"), the lab ("Natera"), or its code ("0340U").
include_retiredNoAlso list retired LCDs/articles for the test category (default false). Contractors re-issue MolDX policies under new numbers, so an older citation may be a retired document.

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observed

TDQS

A4.2/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare read-only, idempotent, open-world behavior, so the safety profile is covered. The description adds real value beyond that: the ordered resolution path (CMS ADLT list, brand-to-code MAAA table, NCBI GTR live) and the brand_not_found failure mode naming every source checked. No notes on auth or rate limits, keeping it below a 5.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Purpose and return values are front-loaded in the first sentence, and the resolution order is well sequenced. The long enumerations of brand names and MAAA tests are verbose but serve semantic matching, so they mostly earn their place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description fully carries the burden: it names the return fields (code, lab, payment, LCDs/articles), the accepted input variants, the source systems, and the not-found contract. An agent can call this correctly without further context.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so both parameters are already documented in the schema, including the include_retired rationale. The description adds only brand/lab/code examples, which partly duplicates the schema's own examples, so the baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb (resolve) and resource (branded molecular/genomic lab test) and enumerates exactly what it returns: CPT PLA/HCPCS code, running lab, Medicare CLFS payment, and MolDX LCDs. This clearly distinguishes it from siblings like medicare_lab_rate or medicare_pricing_coverage.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit example queries ('what does Medicare pay for Signatera') and accepted input forms (brand, lab name, code), plus the fallback behavior when nothing is found. It does not name a specific sibling tool as an alternative, so it stops short of the explicit when-not routing that would earn a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.